Lina Le
Lina Le
Lina Le is a Research Assistant in the Functional Phosphoproteomics group. She holds a Master's in Biomedical Science from the University of Melbourne, Australia.
Her master's research focused on studying long-term immune alterations in Marginal Zone Lymphoma patients undergoing combined therapies of Ibrutinib and Venetoclax at the Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, using spectral and conventional flow cytometry approaches. The study was conducted under the supervision of Professor David Ritchie, Associate Professor Rachel Koldej, and Dr Joanne Davis.
Lina actively contributed as an Executive Committee Member for the Students of the Royal Melbourne (StoRM) Society from 2022 to 2023.
Her master's research focused on studying long-term immune alterations in Marginal Zone Lymphoma patients undergoing combined therapies of Ibrutinib and Venetoclax at the Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, using spectral and conventional flow cytometry approaches. The study was conducted under the supervision of Professor David Ritchie, Associate Professor Rachel Koldej, and Dr Joanne Davis.
Lina actively contributed as an Executive Committee Member for the Students of the Royal Melbourne (StoRM) Society from 2022 to 2023.
Lina Le is a Research Assistant in the Functional Phosphoproteomics group. She holds a Master's in Biomedical Science from the University of Melbourne, Australia.
Her master's research focused on studying long-term immune alterations in Marginal...
Her master's research focused on studying long-term immune alterations in Marginal...
Lina Le is a Research Assistant in the Functional Phosphoproteomics group. She holds a Master's in Biomedical Science from the University of Melbourne, Australia.
Her master's research focused on studying long-term immune alterations in Marginal Zone Lymphoma patients undergoing combined therapies of Ibrutinib and Venetoclax at the Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, using spectral and conventional flow cytometry approaches. The study was conducted under the supervision of Professor David Ritchie, Associate Professor Rachel Koldej, and Dr Joanne Davis.
Lina actively contributed as an Executive Committee Member for the Students of the Royal Melbourne (StoRM) Society from 2022 to 2023.
Her master's research focused on studying long-term immune alterations in Marginal Zone Lymphoma patients undergoing combined therapies of Ibrutinib and Venetoclax at the Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, using spectral and conventional flow cytometry approaches. The study was conducted under the supervision of Professor David Ritchie, Associate Professor Rachel Koldej, and Dr Joanne Davis.
Lina actively contributed as an Executive Committee Member for the Students of the Royal Melbourne (StoRM) Society from 2022 to 2023.
Career information
Share //
